Ventic, Ivy C.

HRN: 28-01-68  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/30/2025
CEFUROXIME 1.5GM (VIAL)
10/30/2025
11/06/2025
IV
1.5gm
Q8
Cholelithiasis
Checking Final Appropriateness 
11/16/2025
CEFUROXIME 1.5GM (VIAL)
11/16/2025
11/23/2025
IV
1.5g
Q8
Cholelithiases
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: